Professional
Added to YB: 2024-09-18
Pitch date: 2024-06-30
TMDX [bullish]
TransMedics Group, Inc.
-17.14%
current return
Author Info
No bio for this author
Company Info
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
Market Cap
$4.5B
Pitch Price
$150.91
Price Target
N/A
Dividend
N/A
EV/EBITDA
35.52
P/E
51.63
EV/Sales
7.99
Sector
Health Care Equipment and Supplies
Category
growth
Wasatch Small Cap Growth Strategy Portfolio Holding: TransMedics Group, Inc.
TMDX: Med-tech co. revolutionizing organ transplants with Organ Care System. OCS replicates organ's natural environment outside body. Stock up on market share gains, increased revenue & earnings. Investors relieved about efficient use of aircraft fleet for organ transport. Long-term competitive advantages remain key thesis.
Read full article (1 min)